Drugs Made in America Ac-RTSDMAARPreferred / convertible
13F holders, Q2 2026 (June 30)28holders −7
2new positions
9sold out
$0.11avg. 13F price*
At the end of Q2 2026, 28 institutions reported holding Drugs Made in America Ac-RTS (DMAAR) in their 13F filings, down 7 from Q1 2026. 2 opened new positions and 9 sold out. The largest holders were Polar Asset Management Partners Inc. ($209K), Linden Advisors LP ($98K) and Mangrove Partners Im, LLC ($94K).
- Company
- Drugs Made in America Ac-RTS
- CUSIP
- G2847J112
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $2K |
| Exits | 9 | $102K |
All 13F filers, Q1 2026 → Q2 2026: 287,608 shares bought and 3,468,938 shares sold, net −3,181,330 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| Polar Asset Management Partners Inc. | — | No change | 1,900,000 | $209K |
| Linden Advisors LP | — | No change | 850,000 | $98K |
| Mangrove Partners Im, LLC | — | No change | 850,000 | $94K |
| Toronto Dominion Bank | — | Add +15.9% | 800,000 | $88K |
| Hudson Bay Capital Management LP | — | Reduce -55.4% | 758,719 | $83K |
| Clear Street Group Inc. | — | Reduce -0.1% | 711,088 | $78K |
| Highbridge Capital Management LLC | — | Reduce -17.9% | 857,493 | $77K |
| Rivernorth Capital Management, LLC | — | No change | 417,998 | $63K |
| Boothbay Fund Management, LLC | — | Reduce -23.8% | 529,898 | $58K |
| Westchester Capital Management, LLC | — | No change | 500,000 | $55K |
| LMR Partners LLP | — | No change | 500,000 | $55K |
| Alpine Global Management, LLC | — | Add +37.9% | 500,000 | $55K |
| Wolverine Asset Management LLC | — | Reduce -31.9% | 471,683 | $52K |
| Whitebox Advisors LLC | — | No change | 400,000 | $44K |
| AQR Arbitrage LLC | — | No change | 372,322 | $37K |
| Shaolin Capital Management LLC | — | Reduce -33.3% | 300,000 | $33K |
| CSS LLC | — | No change | 31,250 | $28K |
| Context Capital Management, LLC | — | No change | 201,016 | $22K |
| Radcliffe Capital Management, L.P. | — | Reduce -37.9% | 143,911 | $17K |
| DLD Asset Management, LP | — | Add +24.6% | 126,594 | $14K |
| BNP Paribas Financial Markets | — | No change | 119,686 | $13K |
| Periscope Capital Inc. | — | No change | 75,000 | $8K |
| Lineage Point Capital LP | — | No change | 50,000 | $6K |
| Gabelli Funds LLC | — | No change | 49,300 | $5K |
| GABELLI & Co INVESTMENT ADVISERS, INC. | — | No change | 48,100 | $5K |
| Readystate Asset Management LP | — | Reduce -37.6% | 31,200 | $3K |
| T3 Companies, LLC | — | New | 15,000 | $2K |
| UBS Group AG | — | New | 108 | $12 |
"% of holder's portfolio" is DMAAR's weight in each manager's 13F, not the share of Drugs Made in America Ac-RTS the manager owns.